Want to see TSE:MYTC full AI Analyst Report?
Top Page
MyndTec, Inc.
(MYTC)
Select Model
Select Model
Rating:40Underperform
Price Target:
C$0.01
▼(-50.00% Downside)
Action:Downgraded
Date:01/27/26
The score is driven primarily by very weak financial performance (shrinking revenue, persistent losses, negative equity, and negative free cash flow). Technicals also weigh heavily as the stock is in a pronounced downtrend (below major moving averages with negative MACD and very low RSI). Valuation impact is limited because P/E and dividend yield are not available.
Positive Factors
Improving gross margin
A sharp TTM improvement in gross margin suggests better unit economics or product mix that could sustain lower per-unit costs. If maintained, this structural improvement supports margin scalability as revenue stabilizes and reduces incremental cash burn needed to operate the business.
Negative Factors
Sharp revenue decline
A ~40% YoY TTM revenue decline is a durable red flag for product-market fit and commercial execution. Sustained top-line contraction impairs operating leverage, magnifies unit-cost absorption issues, and forces higher dependency on external financing to fund operations and clinical or go-to-market activities.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving gross margin
A sharp TTM improvement in gross margin suggests better unit economics or product mix that could sustain lower per-unit costs. If maintained, this structural improvement supports margin scalability as revenue stabilizes and reduces incremental cash burn needed to operate the business.
Read all positive factors
MyndTec, Inc. (MYTC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$146.74K
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)-8.11
Revenue GrowthN/A
EPS GrowthN/A
CountryCA
Employees7
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.04
Shares Outstanding29,348,236
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)-7.02
Price to Sales (P/S)77.96
P/FCF Ratio-9.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MyndTec, Inc. Business Overview & Revenue Model
Company Description
MyndTec Inc. is a medical technology firm dedicated to the research, development, and distribution of therapeutic solutions. Its primary focus is on individuals in Canada and the United States who experience paralysis resulting from stroke or spin...
How the Company Makes Money
MyndTec makes money primarily through the sale and distribution of its flagship product, MyndMove, to healthcare providers, rehabilitation centers, and hospitals. The company generates revenue by offering MyndMove as a service, where customers pay...
MyndTec, Inc. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
14
Very Negative
Cash Flow
16
Very Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 132.67K | 111.43K | 137.31K | 255.80K | 605.57K | 162.63K |
| Gross Profit | 50.95K | 4.86K | 54.90K | 67.44K | 354.62K | 67.04K |
| EBITDA | -1.02M | -1.13M | -1.58M | -1.88M | -2.62M | -1.15M |
| Net Income | -1.09M | -1.25M | -1.72M | -2.25M | -3.34M | -1.81M |
Balance Sheet | ||||||
| Total Assets | 182.68K | 313.57K | 554.85K | 642.57K | 3.82M | 1.65M |
| Cash, Cash Equivalents and Short-Term Investments | 90.21K | 117.48K | 187.41K | 68.62K | 377.06K | 668.58K |
| Total Debt | 429.65K | 463.14K | 455.51K | 734.19K | 2.08M | 1.71M |
| Total Liabilities | 1.45M | 1.55M | 1.47M | 1.57M | 7.37M | 3.48M |
| Stockholders Equity | -1.27M | -1.24M | -919.78K | -925.34K | -3.54M | -1.83M |
Cash Flow | ||||||
| Free Cash Flow | -960.86K | -940.81K | -976.91K | -2.39M | -1.50M | -1.41M |
| Operating Cash Flow | -960.86K | -919.80K | -976.91K | -2.34M | -1.44M | -1.40M |
| Investing Cash Flow | 0.00 | -21.00K | 0.00 | -42.01K | -64.44K | -19.40K |
| Financing Cash Flow | 964.80K | 870.87K | 1.10M | 2.08M | 1.21M | 1.67M |
MyndTec, Inc. Technical Analysis
Negative
0.02
Price Trends
<0.01
Positive
<0.01
Positive
0.02
Negative
Market Momentum
>-0.01
Negative
19.66
Positive
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MYTC, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of <0.01, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 19.66 is Positive, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:MYTC.
MyndTec, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | C$43.73M | -2.16 | -303.05% | ― | 35.27% | 58.34% | |
48 Neutral | C$298.47M | -6.11 | -62.45% | ― | 59.60% | 32.53% | |
43 Neutral | C$54.33M | -12.32 | -130.04% | ― | -24.86% | 18.29% | |
43 Neutral | C$275.99K | -0.18 | 23.95% | ― | 8.66% | -545.88% | |
40 Underperform | C$146.74K | -0.17 | 59.85% | ― | ― | ― |
* Healthcare Sector Average
TSE:MYTC
MyndTec, Inc.
0.01
-0.07
-87.50%
TSE:PINK
Perimeter Medical Imaging AI
0.28
0.06
27.27%
TSE:PRN
Profound Medical
8.41
1.61
23.68%
TSE:TLT
Theralase Technologies
0.18
-0.02
-7.89%
TSE:ASTI
Aquarius Surgical Technologies
0.01
0.00
0.00%
MyndTec, Inc. Corporate Events
Business Operations and StrategyPrivate Placements and Financing
MyndTec Raises Over $1.06 Million as It Closes Tenth Tranche of Private Placement
Positive
Jan 7, 2026
MyndTec Inc. has completed a tenth tranche of its non-brokered private placement, issuing 618,118 units at $0.20 per unit for gross proceeds of $123,623.60, bringing total funds raised under the offering to $1,067,493.40 through 5,337,323 units. E...
Private Placements and Financing
MyndTec Completes Ninth Tranche of Private Placement
Neutral
Dec 12, 2025
MyndTec Inc. has completed the ninth tranche of its non-brokered private placement, raising $110,785.20 through the issuance of 553,926 units, each comprising one common share and a half-share purchase warrant. The proceeds will be used for genera...
Financial DisclosuresPrivate Placements and Financing
MyndTec Inc. Corrects Private Placement Figures in Recent Press Release
Neutral
Dec 5, 2025
MyndTec Inc. announced a correction to its previous press release regarding the eighth tranche of its non-brokered private placement, adjusting the number of units issued and the aggregate gross proceeds. The correction does not affect other detai...
Business Operations and StrategyExecutive/Board Changes
MyndTec Inc. Announces Board Resignation of P. Harvey Griggs
Negative
Nov 27, 2025
MyndTec Inc. announced the resignation of P. Harvey Griggs from its Board of Directors, effective November 26, 2025, due to personal health reasons. Dr. Griggs, an early investor and six-year director, was praised for his contributions to the comp...
Business Operations and StrategyPrivate Placements and Financing
MyndTec Completes Seventh Tranche of Private Placement, Strengthening Financial Position
Positive
Nov 5, 2025
MyndTec Inc. has successfully completed the seventh tranche of its non-brokered private placement, raising $52,451.25 through the issuance of 262,027 Units at $0.20 per Unit. This brings the total proceeds from the offering to $762,529.60. The fun...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.